Pay in 4 interest-free payments of $7.10 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
How These Results Compare to Other Weight Loss Medicines Retatrutide's 24.2% mean weight loss at 48 weeks exceeds phase 3 data for semaglutide 2.4 mg (~14.9% at 68 weeks) and is comparable to tirzepatide 15 mg (~22.5% at 72 weeks), though no direct head-to-head trials have been conducted
The differences and similarities between these drugs and all their brand names are legitimately confusing, said Stanford Medicine endocrinologist Sun Kim, MD
3-12 For those agents approved for both obesity and type 2 diabetes, the dosing schedule and maximum dosage differ for each condition
GHRP-6 (2 mg Vial) Stimulates GH release for muscle growth, fat loss, and recovery.
Your journey continues even when medication stops
US$ 21.03
US$ 22.68
US$ 22.56
US$ 21.14
US$ 21.86
US$ 20.15
